[
 {
   "VC Name": "V-bio Ventures",
   "Location": "Gent, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage",
   "Research": {
      " Industry Partner": "VIB"
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "",
   "Website": "http://v-bio.ventures/"
},
 {
   "VC Name": "Capricorn VP",
   "Location": "Leuven, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2014",
   "Special Criteria": "",
   "Website": "http://www.capricorn.be/"
},
 {
   "VC Name": "Saffelberg Investments",
   "Location": "Gooik, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Early stage, Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.saffelberg.com/"
},
 {
   "VC Name": "Qbic Fund",
   "Location": "Gent, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage",
   "Research": {
      " Industry Partner": "Uni Gent"
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "Link with Gent University",
   "Website": "http://qbic.be/"
},
 {
   "VC Name": "PMV",
   "Location": "Brussels, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Ever green",
   "Special Criteria": "Link with the flemish region",
   "Website": "http://www.pmv.eu/en"
},
 {
   "VC Name": "GIMV",
   "Location": "Antwerp, Belgium, HT The Hague, Netherlands, Paris, France, Munich, Germany",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Public",
   "Special Criteria": "",
   "Website": "http://www.gimv.com/en"
},
 {
   "VC Name": "Fund Plus",
   "Location": "Leuven, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices",
   "Prefered Indication": "",
   "Investment Stage": "Early stage, Late stage",
   "Research": {
      " Industry Partner": "LS Research Partners"
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "",
   "Website": "http://fundplus.be/"
},
 {
   "VC Name": "Cascara Ventures",
   "Location": "Brussels, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "https://www.cascaraventures.com/"
},
 {
   "VC Name": "Vives Fund",
   "Location": "Louvain, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage",
   "Research": {
      " Industry Partner": "UCL-Louvain"
   },
   "Fund Status": "Latest raising in 2011",
   "Special Criteria": "Link with UCL-Louvain",
   "Website": "http://www.vivesfund.com/en/"
},
 {
   "VC Name": "Gemma Frisius Fund",
   "Location": "Leuven, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage",
   "Research": {
      " Industry Partner": "KU-Leuven"
   },
   "Fund Status": "Ever green",
   "Special Criteria": "Link with KU-Leuven",
   "Website": "https://lrd.kuleuven.be/en/spinoff/gemma-frisius-fund"
},
 {
   "VC Name": "Korys",
   "Location": "Brussels, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Early stage, Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Ever green",
   "Special Criteria": "",
   "Website": "http://www.korys.be/"
},
 {
   "VC Name": "Agri Investment Fund ",
   "Location": "Leuven, Belgium",
   "Investment Focus": "Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.aifund.be/en"
},
 {
   "VC Name": "Droia Oncology Ventures",
   "Location": "Meise, Belgium, Luxembourg",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Oncology",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://droia.be/"
},
 {
   "VC Name": "Theodorus Fund",
   "Location": "Brussels, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech, Agrobio",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage",
   "Research": {
      " Industry Partner": "ULB University"
   },
   "Fund Status": "",
   "Special Criteria": "Link with ULB University",
   "Website": "http://www.theodorus.be/en"
},
 {
   "VC Name": "Merifin Capital",
   "Location": "Brussels, Belgium",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech",
   "Prefered Indication": "",
   "Investment Stage": "Early stage, Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.merifin.com/overview-investment.aspx"
},
 {
   "VC Name": "CD3 Fund",
   "Location": "Leuven, Belgium",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage",
   "Research": {
      " Industry Partner": "KU Leuven"
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "http://www.cd3.eu/"
},
 {
   "VC Name": "Vesalius Biocapital",
   "Location": "Luxembourg",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Located in Europe",
   "Website": "http://www.vesaliusbiocapital.com/home"
},
 {
   "VC Name": "Omnes Capital",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics, Diagnostics, Medical devices, Health-tech",
   "Prefered Indication": "",
   "Investment Stage": "Seed, Early stage, Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Ever green",
   "Special Criteria": "",
   "Website": "https://www.omnescapital.com/en"
},
 {
   "VC Name": "Seventure",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.seventure.fr/en/"
},
 {
   "VC Name": "Sofinnova Parteners",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.sofinnova.fr/en/"
},
 {
   "VC Name": "Edmond De Rothschild",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.edmond-de-rothschild.com/site/France/en/private-equity/our-expertise/life-sciences"
},
 {
   "VC Name": "Kurma Partners",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "",
   "Website": "http://www.kurmapartners.com/en/"
},
 {
   "VC Name": "Inserm Transfert Initiative",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2011",
   "Special Criteria": "",
   "Website": "http://www.inserm-transfert-initiative.com/en/?orders[order]=order&tags_id=2&issearch=1"
},
 {
   "VC Name": "Advent France Biotech",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "",
   "Website": "http://www.adventfb.com/en/"
},
 {
   "VC Name": "CapAgro",
   "Location": "Paris, France",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2014",
   "Special Criteria": "",
   "Website": "https://www.capagro.fr/copie-de-accueil"
},
 {
   "VC Name": "Auriga VC",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.auriga.vc/"
},
 {
   "VC Name": "Pierre Fabre Fund",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Oncology - Dermatology",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "https://www.pierre-fabre.com/en/pierre-fabre-fund-innovation"
},
 {
   "VC Name": "Truffle Capital",
   "Location": "Paris, France",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2017",
   "Special Criteria": "",
   "Website": "http://www.truffle.com/"
},
 {
   "VC Name": "Forbion Capital Partners",
   "Location": "Naarden, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "https://forbion.com/en/"
},
 {
   "VC Name": "Biogeneration Ventures",
   "Location": "Naarden, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "Located in Benelux or Germany",
   "Website": "http://www.biogenerationventures.com/"
},
 {
   "VC Name": "Anterra Capital",
   "Location": "Amsterdam, Netherlands",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "http://www.anterracapital.com/"
},
 {
   "VC Name": "Merck Ventures",
   "Location": "Amsterdam, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": "Merck KGaA"
   },
   "Fund Status": "Ever Green",
   "Special Criteria": "Match with Merck KGaA strategy",
   "Website": "http://merck-ventures.com/"
},
 {
   "VC Name": "Thuja Capital",
   "Location": "Utrecht, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "Located  in Benelux",
   "Website": "http://thujacapital.com/"
},
 {
   "VC Name": "Aglaia Biomedical Venntures",
   "Location": "Bilthoven, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Oncology",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.aglaia-biomedical.com/"
},
 {
   "VC Name": "Gilde Healthcare",
   "Location": "Utrecht, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "https://gildehealthcare.com/"
},
 {
   "VC Name": "Swanbridge Capital",
   "Location": "Rotterdam, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://swanbridgecapital.nl/"
},
 {
   "VC Name": "BOM Capital",
   "Location": "De Tilburg, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Link with Noord-Brabant",
   "Website": "https://www.bom.nl/"
},
 {
   "VC Name": "Inkef Capital",
   "Location": "Amsterdam, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "Located in Netherlands",
   "Website": "http://www.inkefcapital.com/"
},
 {
   "VC Name": "LSP ",
   "Location": "Amsterdam, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2014",
   "Special Criteria": "",
   "Website": "https://lspvc.com/"
},
 {
   "VC Name": "DSM Venturing",
   "Location": "TE Heerlen, Netherlands",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "https://www.dsm.com/corporate/about/business-entities/dsm-venturing.html"
},
 {
   "VC Name": "Lupus Ventures",
   "Location": "Heerenveen, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Oncology",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Located in Netherlands",
   "Website": "http://lupusventures.nl/"
},
 {
   "VC Name": "Eserante Ventures",
   "Location": "Hofddorp, Netherlands",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.esperanteventures.com/"
},
 {
   "VC Name": "EMBL Ventures",
   "Location": "Heidelberg, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": "EMBL Heidelberg"
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.embl-ventures.com/"
},
 {
   "VC Name": "Wellington Partners",
   "Location": "Munich, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.wellington-partners.com/welcome/"
},
 {
   "VC Name": "Fraunhofer Venture",
   "Location": "Munich, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": "Frauenhofer-Gesellschaft"
   },
   "Fund Status": "",
   "Special Criteria": "Frauenhofer Spin-off",
   "Website": "https://www.fraunhoferventure.de/en.html"
},
 {
   "VC Name": "MIG AG",
   "Location": "Munich, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2014",
   "Special Criteria": "",
   "Website": "http://www.mig.ag/de/"
},
 {
   "VC Name": "SHS Capital",
   "Location": "Tubingen, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2013",
   "Special Criteria": "Located in DACH",
   "Website": "http://www.shs-capital.eu/en/"
},
 {
   "VC Name": "LBBW Venture ",
   "Location": "Stuttgart, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Link with BW or RLP provinces",
   "Website": "http://www.lbbw-venture.de/"
},
 {
   "VC Name": "High-Tech Gründerfonds",
   "Location": "Bonn, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "https://high-tech-gruenderfonds.de/en/#title"
},
 {
   "VC Name": "Boehringer Venture Fund",
   "Location": "Ingelheim, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Immuno-Oncology, Regenerative medicine, therpeutic modalities, Microbiome",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.boehringer-ingelheim-venture.com/"
},
 {
   "VC Name": "Dievini",
   "Location": "Heidelberg, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Oncology, Neurology, infectious diseases, cell therapy, drug delivery systems",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.dievini.com/content/index.php?seite=33&sprache=2"
},
 {
   "VC Name": "Creathor Venture",
   "Location": "Bad Homburg, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2011",
   "Special Criteria": "Located in DACH, France or Nordic countries",
   "Website": "http://www.creathor.com/en/"
},
 {
   "VC Name": "IBB Beteiligungsgesellschaft",
   "Location": "Berlin, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Based in Berlin",
   "Website": "http://www.ibb-bet.de/en/home.html"
},
 {
   "VC Name": "Peppermint Venture Partners",
   "Location": "Berlin, Germany",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": "Charite Berlin"
   },
   "Fund Status": "Latest raising in 2010",
   "Special Criteria": "",
   "Website": "http://www.peppermint-vp.com/"
},
 {
   "VC Name": "Earlybird Ventures",
   "Location": "Berlin, Germany",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "https://www.earlybird.com/"
},
 {
   "VC Name": "BtoV Partners",
   "Location": "Berlin, Germany",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "https://btov.vc/"
},
 {
   "VC Name": "Medicis Capital",
   "Location": "Munich, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Located in western Europe",
   "Website": "http://www.medicis.de/About-Us"
},
 {
   "VC Name": "TVM Capital",
   "Location": "Munich, Germany",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2014",
   "Special Criteria": "",
   "Website": "http://www.tvm-capital.com/"
},
 {
   "VC Name": "Sunstone ",
   "Location": "Copenhagen, Denmark",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2012",
   "Special Criteria": "",
   "Website": "http://life.sunstone.eu/"
},
 {
   "VC Name": "NOVO Holdings",
   "Location": "Hellerup, Denmark",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": "Novo Nordisk"
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.novoholdings.dk/novo/novo"
},
 {
   "VC Name": "NB Capital",
   "Location": "Copenhagen, Denmark",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://nbcapital.net/"
},
 {
   "VC Name": "Lundbeck fund",
   "Location": "Copenhagen, Denmark",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": "Lundbeck Foundation"
   },
   "Fund Status": "Ever green",
   "Special Criteria": "",
   "Website": "https://www.lundbeckfonden.com/en/"
},
 {
   "VC Name": "HealthCap",
   "Location": "Stockholm, Sweden",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Oncology, Orphan diseases, Genetic diseases",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.healthcap.eu/"
},
 {
   "VC Name": "SEB Venture Capital",
   "Location": "Stockholm, Sweden",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Ever green",
   "Special Criteria": "",
   "Website": "https://sebgroup.com/large-corporates-and-institutions/our-services/seb-venture-capital"
},
 {
   "VC Name": "InnovationsKapital",
   "Location": "Stockholm, Sweden",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Public",
   "Special Criteria": "",
   "Website": "http://www.innkap.se/"
},
 {
   "VC Name": "Ysios Capital",
   "Location": "Barcelona, Spain",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "http://www.ysioscapital.com/"
},
 {
   "VC Name": "Alta Life Science",
   "Location": "Barcelona, Spain",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Located in Spain",
   "Website": "https://www.altals.com/"
},
 {
   "VC Name": "CRB Inverbio",
   "Location": "Madrid, Spain",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2012",
   "Special Criteria": "",
   "Website": "http://crbinverbio.com/en/#.WcqF-8hJZPY"
},
 {
   "VC Name": "Healthequity ",
   "Location": "Barcelona, Spain",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2012",
   "Special Criteria": "Located in Catalonia (preferably)",
   "Website": "http://healthequity.es/index_eng.html"
},
 {
   "VC Name": "Inveready",
   "Location": "Barcelona, Spain",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://inveready.com/venture-capital/"
},
 {
   "VC Name": "Caixa Capital Risc",
   "Location": "Barcelona, Spain",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.caixacapitalrisc.es/en/vehiculos-de-inversion/"
},
 {
   "VC Name": "Nextech Invest",
   "Location": "Zurich, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Oncology",
   "Investment Stage": "Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2017",
   "Special Criteria": "",
   "Website": "https://www.nextechinvest.com/en/"
},
 {
   "VC Name": "Emerald Technology Ventures",
   "Location": "Zurich, Switzerland",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.emerald-ventures.com/#"
},
 {
   "VC Name": "HBM Healthcare Investments",
   "Location": "Zug, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Public",
   "Special Criteria": "",
   "Website": "http://www.hbmhealthcare.com/en/unternehmen/profil.php"
},
 {
   "VC Name": "VI Partners",
   "Location": "Zug, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Ever green",
   "Special Criteria": "Located in Switzerland (preferably)",
   "Website": "http://www.vipartners.ch/"
},
 {
   "VC Name": "Biomed Partners",
   "Location": "Basel, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2017",
   "Special Criteria": "Located in Switzerland and neighbours",
   "Website": "https://biomedvc.com/en/"
},
 {
   "VC Name": "Novartis Venture Fund",
   "Location": "Basel, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": "Novartis"
   },
   "Fund Status": "Ever green",
   "Special Criteria": "",
   "Website": "http://www.nvfund.com/#Home"
},
 {
   "VC Name": "Roche Venture Fund",
   "Location": "Basel, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": "Roche"
   },
   "Fund Status": "Ever green",
   "Special Criteria": "",
   "Website": "https://www.roche.com/venturefund.htm"
},
 {
   "VC Name": "Endeavour Vision",
   "Location": "Geneva, Switzerland",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.endeavourvision.com/"
},
 {
   "VC Name": "Neomed Ventures",
   "Location": "Geneva, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "",
   "Website": "http://neomed.net/"
},
 {
   "VC Name": "Eclosion Ventures",
   "Location": "Geneva, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://eclosionventures.com/"
},
 {
   "VC Name": "Aravis Capital",
   "Location": "Zurich, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Oncology, Autoimmune diseases, Personalized therapies",
   "Investment Stage": "Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2017",
   "Special Criteria": "",
   "Website": "https://www.aravis.ch/"
},
 {
   "VC Name": "BB Biotech Ventures",
   "Location": "Zurich, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": "Bellevue Asset Management"
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.bbbiotechventures.com/en/bb-biotech-ventures/"
},
 {
   "VC Name": "BlueOcean Ventures",
   "Location": "Geneva, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "",
   "Website": "http://blueocean-ventures.com/"
},
 {
   "VC Name": "Lifecare Partners",
   "Location": "Basel, Switzerland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.lifecarevc.com"
},
 {
   "VC Name": "Fountain Healthcare Partners",
   "Location": "Dublin, Irland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "",
   "Website": "http://www.fh-partners.com/"
},
 {
   "VC Name": "Malin PLC",
   "Location": "Dublin, Irland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Public",
   "Special Criteria": "",
   "Website": "http://www.malinplc.com/"
},
 {
   "VC Name": "Seroba Life Sciences",
   "Location": "Dublin, Irland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "http://www.seroba-lifesciences.com/"
},
 {
   "VC Name": "Polaris Partners",
   "Location": "Dublin, Irland",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2017",
   "Special Criteria": "",
   "Website": "http://www.polarispartners.com/healthcare/"
},
 {
   "VC Name": "Delta Partners",
   "Location": "Dublin, Irland",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.deltapartners.com/"
},
 {
   "VC Name": "Joint Polish Investment Fund",
   "Location": "Warsaw, Poland",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "Link with Poland",
   "Website": "http://www.jpifund.com/"
},
 {
   "VC Name": "Life Science Capital",
   "Location": "Roma, Italy",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.lscap.it/eng/index.html"
},
 {
   "VC Name": "Panakes Partners",
   "Location": "Milano, Italy",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "",
   "Website": "http://www.panakes.it/"
},
 {
   "VC Name": "Principia SGR",
   "Location": "Milano, Italy",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "Link with Italy",
   "Website": "http://principiasgr.it/?lang=en"
},
 {
   "VC Name": "Abingworth LLP",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "https://www.abingworth.com/"
},
 {
   "VC Name": "Tate & Lyle Ventures",
   "Location": "London, UK",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.tateandlyleventures.com/"
},
 {
   "VC Name": "Johnson & Johnson Innovation",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": "Johnson & Johnson"
   },
   "Fund Status": "Ever green",
   "Special Criteria": "",
   "Website": "https://www.jnjinnovation.com/jjdc"
},
 {
   "VC Name": "UCTL Technology Fund",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": "Managed by Albion Capital"
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "http://www.ucltf.co.uk/"
},
 {
   "VC Name": "MVM Partners ",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "",
   "Website": "http://www.mvm.com/"
},
 {
   "VC Name": "Touchstone Innovation",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": "Universities of Oxford, Cambridge and College London"
   },
   "Fund Status": "Public",
   "Special Criteria": "Based in London, Cambridge or Oxford",
   "Website": "https://www.touchstoneinnovations.com/"
},
 {
   "VC Name": "Inventages",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.inventages.com/"
},
 {
   "VC Name": "Dementia Discovery Fund",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Dementia",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": "Alzheimer's research UK, managed by SV Life Science"
   },
   "Fund Status": "Latest raising in 2015",
   "Special Criteria": "",
   "Website": "http://theddfund.com/"
},
 {
   "VC Name": "SV Health Investors",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2017",
   "Special Criteria": "",
   "Website": "http://svhealthinvestors.com/"
},
 {
   "VC Name": "SR One",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": "GSK"
   },
   "Fund Status": "Ever green",
   "Special Criteria": "",
   "Website": "http://www.srone.com/"
},
 {
   "VC Name": "Syncona",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Public",
   "Special Criteria": "",
   "Website": "https://www.synconaltd.com/"
},
 {
   "VC Name": "Spark Ventures",
   "Location": "London, UK",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.sparkventuremanagement.com/"
},
 {
   "VC Name": "Epidarex",
   "Location": "Edinburgh, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": "Eli Lilly, King's College London"
   },
   "Fund Status": "Latest raising in 2017",
   "Special Criteria": "",
   "Website": "http://www.epidarex.com/"
},
 {
   "VC Name": "Sixth Element Capital",
   "Location": "Berkhamsted, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "Oncology",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": "Cancer Research UK"
   },
   "Fund Status": "Latest raising in 2012",
   "Special Criteria": "",
   "Website": "http://www.sixthelementcapital.com/"
},
 {
   "VC Name": "Medicxi Ventures",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2016",
   "Special Criteria": "Centric asset companies",
   "Website": "https://www.medicxiventures.com/"
},
 {
   "VC Name": "Advent Life Sciences",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2014",
   "Special Criteria": "",
   "Website": "http://www.adventls.com/"
},
 {
   "VC Name": "Albion Capital",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2017",
   "Special Criteria": "",
   "Website": "https://www.albion.capital/"
},
 {
   "VC Name": "Amedua Capital",
   "Location": "London, UK",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "https://www.amadeuscapital.com/#introduction"
},
 {
   "VC Name": "ET Capital",
   "Location": "Cambridge, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Based in London, Cambridge, Oxford",
   "Website": "http://www.etcapital.com/"
},
 {
   "VC Name": "Longbow Capital",
   "Location": "Norwich, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2013",
   "Special Criteria": "Located in UK",
   "Website": "http://www.longbow.co.uk/"
},
 {
   "VC Name": "Longwall Venture Partners",
   "Location": "Oxford, UK",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Located in UK",
   "Website": "http://www.longwallventures.com/"
},
 {
   "VC Name": "Mercia Fund Management",
   "Location": "Henley-in-Arden, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Located in UK",
   "Website": "http://www.merciafund.co.uk/"
},
 {
   "VC Name": "MTI Ventures",
   "Location": "Edinburgh, UK",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": "University of Manchester"
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.mtiventures.com/"
},
 {
   "VC Name": "New Hill Management",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Located in UK",
   "Website": "http://www.newhillmgt.com/"
},
 {
   "VC Name": "Phase4 Partners",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.phase4-partners.com/"
},
 {
   "VC Name": "Spark Impact",
   "Location": "Liverpool, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Fully invested",
   "Special Criteria": "",
   "Website": "http://sparkimpact.co.uk/"
},
 {
   "VC Name": "Stage Capital",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.stagecap.com/"
},
 {
   "VC Name": "Entrepreneurs Fund",
   "Location": "London, UK",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.entrepreneursfund.com/"
},
 {
   "VC Name": "Aquagro Fund",
   "Location": "Tel Aviv, Israel",
   "Investment Focus": "",
   "Prefered Indication": "",
   "Investment Stage": "Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "https://www.aquagrofund.com/"
},
 {
   "VC Name": "Clal Biotechnology Industries",
   "Location": "Tel Aviv, Israel",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Public",
   "Special Criteria": "",
   "Website": "http://cbi.co.il/"
},
 {
   "VC Name": "Evergreen Venture Partners",
   "Location": "Tel Aviv, Israel",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "Located in Israel",
   "Website": "http://www.evergreen.co.il/"
},
 {
   "VC Name": "Israel HealthCare Ventures",
   "Location": "Tel Aviv, Israel",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Early stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2006",
   "Special Criteria": "Located in Israel",
   "Website": "http://www.ihcv.co.il/"
},
 {
   "VC Name": "Medica Partners",
   "Location": "Herzeliya, Israel",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Late stage",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.medicavp.com/#page_1/"
},
 {
   "VC Name": "Pontifax Venture Capital",
   "Location": "Herzeliya, Israel",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "",
   "Special Criteria": "",
   "Website": "http://www.pontifax.com/"
},
 {
   "VC Name": "OrbiMed",
   "Location": "Herzeliya, Israel",
   "Investment Focus": "Therapeutics",
   "Prefered Indication": "",
   "Investment Stage": "Seed",
   "Research": {
      " Industry Partner": ""
   },
   "Fund Status": "Latest raising in 2017",
   "Special Criteria": "",
   "Website": "http://www.orbimed.com/"
}
]